Innovex To Deploy Specialty Sales Representatives
PARSIPPANY, N.J., April 5 /PRNewswire-FirstCall/ -- Innovex, the
commercialization unit of Quintiles Transnational Corp., and StoneBridge
Pharma LLC, a specialty pharmaceutical company, today announced an agreement
that calls for the deployment of at least three waves of specialty sales
representatives over the next 12 months. Innovex will provide teams of up to
75 specialty sales representatives across the country to support StoneBridge's
sales and marketing efforts.
StoneBridge Pharma selected Innovex to support its sales efforts based on
Innovex's proven track record for deploying Specialty Sales teams, as well as
their analytical capabilities, which will assist StoneBridge with their
strategic targeting efforts. StoneBridge Pharma products are focused in the
gastroenterology, ophthalmology and women's health therapeutic areas.
"The selection of Innovex to support our sales efforts was based on the
company's reputation for providing intelligent sales solutions. Innovex
offered superior resources to back our sales professionals, and their use of
analytics in strategically segmenting the market will greatly improve the
effectiveness of our sales force," said Bob Sykora, President of StoneBridge.
"We are looking forward to demonstrating our sales expertise to
StoneBridge Pharma," said Tony Yost, President of Innovex U.S. "We won this
business because of our innovative use of analytics to improve sales force
effectiveness and our ability to rapidly recruit and deploy experienced sales
professionals. We go beyond simply providing sales representatives as our
people are empowered by information and technologies that enhance sales
planning, tracking and results."
About Innovex
Innovex, the commercialization division of Quintiles Transnational Corp.,
is a leading commercial solutions provider that offers sales and marketing
services designed to accelerate the success of pharmaceutical, biotechnology
and medical device products. Since 1996, Innovex has built more than 150
sales and Health Management Services teams, and hired more than 16,000 sales
representatives and 500 clinicians to help launch more than 160 products for
leading pharmaceutical companies in the United States. For more information,
visit http://www.innovex.com.
Quintiles is the global leader in pharmaceutical services. We improve
healthcare worldwide by providing quality professional expertise, market
intelligence and innovative partnering solutions to the pharmaceutical,
biotechnology and healthcare industries. Quintiles has 16,000 specialized
employees and offices in 50 countries. For more information visit the
company's Web site at http://www.quintiles.com.
This press release contains "forward-looking statements" regarding
Quintiles that involve risks and uncertainties that could cause actual results
to differ materially, including, without limitation, the risk that the market
for our products and services will not grow as we expect, our ability to
efficiently distribute backlog among therapeutic business units and match
demand to resources, actual operating performance, the ability to maintain
large client contracts or to enter new contracts, changes in trends in the
pharmaceutical industry and the ability to operate successfully in new lines
of business. Additional factors that could cause actual results to differ
materially are discussed in Quintiles' recent filings with the Securities and
Exchange Commission, including but not limited to its Annual Report on Form
10-K, its Form 8-Ks, and its other periodic reports, including Form 10-Qs.
About StoneBridge
StoneBridge Pharma, a Georgia-based LLC, is a specialty pharmaceutical
company focused on solutions to address unmet needs that are clinically useful
and financially advantageous to the patient, physician and StoneBridge in the
areas of gastroenterology, ophthalmology and women's health. Since its
creation in 2005, StoneBridge has cultivated a culture that values
entrepreneurial zeal, innovation, market knowledge and service excellence in
order to identify the most critical healthcare issues for its market segments,
develop solutions to those issues and measurably improve quality of care.
StoneBridge Pharma has a simple -- yet powerful -- business strategy:
1. Seek partnerships with companies that have successful and proven
products.
2. Use the knowledge and expertise of a management team with more than a
century of collective experience in the pharmaceutical industry.
3. Maximize the performance of a specialized and highly targeted sales
and marketing team.
4. Use a variety of approaches to revitalize and re-market products such
as:
a. Marketing new drug delivery methods or formulations
b. Initiate special sales and marketing programs through the focused
sales team
StoneBridge Pharma is a leader in alliance management with its focused
approach of maximizing value from product initiation through product maturity
to lifecycle optimization, following patent expiration. For more information,
visit the company's website at http://www.stonebridgepharma.com.
SOURCE Quintiles Transnational Corp.
 back to top
Related links:
http://www.innovex.com
http://www.quintiles.com http://www.stonebridgepharma.com
CONTACT:
Mari Mansfield, media relations of Quintiles
Transnational Corp., +1-919-998-2639, or
mari.mansfield@quintiles.com; or Robert C. Sykora, RPh, President
of StoneBridge Pharma, +1-877-528-6593, or
rsykora@stonebridge.com
|
